Loading...
XLON
SUN
Market cap8mUSD
Jul 11, Last price  
0.70GBP
1D
0.00%
1Q
40.00%
Jan 2017
-83.53%
Name

Surgical Innovations Group PLC

Chart & Performance

D1W1MN
P/E
P/S
54.35
EPS
Div Yield, %
Shrs. gr., 5y
2.37%
Rev. gr., 5y
1.84%
Revenues
12m
+5.94%
3,032,0004,018,0004,460,0004,770,0004,312,0004,541,0007,045,0007,602,0007,639,0008,553,0004,029,0005,468,0006,089,0008,752,00010,969,00010,733,0006,329,0009,126,00011,340,00012,014,000
Net income
-509k
L
212,000402,000696,000765,000630,000525,0001,788,0001,738,000686,000800,000-9,457,000-2,033,000716,000626,000725,000-2,619,000-3,276,000-456,000264,000-509,000
CFO
400k
-17.70%
80,000230,000625,000-428,0007,0001,439,0002,202,0001,775,000612,0001,268,000-485,0001,506,0002,845,0001,608,0001,650,000594,0001,042,000-433,000486,000400,000
Earnings
Sep 29, 2025

Profile

Surgical Innovations Group plc, together with its subsidiaries, designs, develops, manufactures, and sells devices for use in minimally invasive surgery (SI) and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company's SI Brand segment researches, develops, manufactures, and distributes SI branded minimally invasive devices. This segment also offers YelloPort Elite and YelloPort +plus laparoscopic port access systems; LogiRange resposable laparoscopic instrument systems; FastClamp laparoscopic clamping systems; and QuickRange single use laparoscopic instrumentation. Its OEM segment researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding. This segment also provides design and development solutions for producing a final device; and researches, develops, manufactures, and sells minimally invasive technology products for precision engineering applications. The company's Distribution segment distributes medical products through Elemental Healthcare Ltd. It also designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was incorporated in 1988 and is based in Leeds, the United Kingdom.
IPO date
Jul 07, 1998
Employees
92
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
12,014
5.94%
11,340
24.26%
Cost of revenue
12,572
11,000
Unusual Expense (Income)
NOPBT
(558)
340
NOPBT Margin
3.00%
Operating Taxes
(219)
(321)
Tax Rate
NOPAT
(339)
661
Net income
(509)
-292.80%
264
-157.89%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
611
614
Long-term debt
1,859
2,501
Deferred revenue
Other long-term liabilities
165
165
Net debt
1,258
916
Cash flow
Cash from operating activities
400
486
CAPEX
(284)
(1,078)
Cash from investing activities
(688)
(1,078)
Cash from financing activities
(672)
(935)
FCF
1,154
(270)
Balance
Cash
1,212
2,199
Long term investments
Excess cash
611
1,632
Stockholders' equity
3,897
3,126
Invested Capital
11,700
11,485
ROIC
6.00%
ROCE
2.59%
EV
Common stock shares outstanding
932,816
935,946
Price
0.01
-62.50%
0.02
-31.91%
Market cap
5,597
-62.63%
14,975
-31.96%
EV
6,855
15,891
EBITDA
199
927
EV/EBITDA
34.45
17.14
Interest
132
98
Interest/NOPBT
28.82%